Long-term follow-up of a phase 2 study of oral...

Long-term follow-up of a phase 2 study of oral teriflunomide in relapsing multiple sclerosis: safety and efficacy results up to 8.5 years

Confavreux, C., Li, D. K., Freedman, M. S., Truffinet, P., Benzerdjeb, H., Wang, D., Bar-Or, A., Traboulsee, A. L., Reiman, L. E., O'Connor, P. W.

How much do you like this book?

What’s the quality of the file?

Download the book for quality assessment

What’s the quality of the downloaded files?

Volume:

Language:

english

Journal:

Multiple Sclerosis Journal

DOI:

10.1177/1352458512436594

Date:

September, 2012

File:

PDF, 363 KB

english, 2012

Conversion to is in progress

Conversion to is failed